Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans
Posted on: Tuesday, 15 April 2008, 12:00 CDT
WASHINGTON, April 15 /PRNewswire/ -- Avalere Health today reminded consumers to pay close attention to all aspects of their Medicare prescription drug plan, including on which "tier" or group their medications are covered. Avalere data released from its proprietary DataFrame(R) database show that an overwhelming majority of Medicare health plans are now using a system that places some of the most expensive drugs in newly created fourth and fifth tiers. Drugs in the higher tiers can cost consumers significantly more money than a three tier, fixed co-payment system.
Consumers traditionally pay fixed amounts, or co-pays, when purchasing prescription drugs, and these co-pays are typically lumped into three groups: generics, preferred brands, and non-preferred brands. However, Medicare Part D drug plans have revolutionized the shape of the market by placing more expensive drugs into additional tiers. According to Avalere, 86% of all Medicare Part D plans use four (and sometimes five) tier plan structures, versus only 10% of commercial health plans.
"Health plans are trying to balance competing demands of access to medications and low cost, but the result is that patients with serious illnesses are paying more," said Dan Mendelson, president of Avalere Health. "It's a trend that's starting to push into the commercial world too."
Using its proprietary DataFrame database, which houses information about every Medicare drug plans' drug coverage and associated benefits, found that on average, Medicare Part D beneficiaries pay 25 percent to 35 percent of the cost of Tier 4 drugs compared with commercial plan beneficiaries who pay a fixed fee of about $71. Specialty drugs found in Tier 4 formularies can cost in excess of $600 per month.
"People with cancer, multiple sclerosis, hepatitis C, rheumatoid arthritis, and anemia should be paying very close attention to tiering in Medicare," said Mendelson.
Other facts released by Avalere: -- Among Medicare's top 10 Part D plans, 9 use Tier 4 formularies; -- The average co-payment for 4th Tier drugs in the Medicare community is $70; -- The average co-payment for 3rd Tier or non-preferred drugs in the Medicare community is $40; -- Medicare patients generally pay about $20 for preferred prescriptions, and $10 for generic drugs.
For graphics you can use for media stories, please contact Kim Coghill at kcoghill@avalerehealth.net. For more information about Avalere's DataFrame database and the Medicare marketplace, contact Brian Bruen at bbruen@avalerehealth.net.
Avalere Health
CONTACT: Lindsey Spindle of Avalere Health, +1-202-207-1337,lspindle@avalerehealth.net
Web site: http://www.avalerehealth.net/
Source: PRNewswire
Related Articles
- Avalere Report Shows Unapproved Prescription Drugs Dropped From CMS Formulary Reference File
- Health Plans Highlight Value of Medicare Advantage Special Needs Plans
- Senior Whole Health Expands Medicare Advantage Special Needs Plan Coverage Area to Include Fairfield County, Conn.
- Health Plans Participate in CMS PHR Pilot to Help Medicare Beneficiaries Better Manage Their Health
- Government Interference in Drug Negotiations Undermines Safety and Puts Part D Program at Risk - Academy of Managed Care Pharmacy Testimony to Senate Finance Committee
- Seniors Struggle to Get Drug Plans to Pay for Some Prescriptions
- FDA Raps Biogen's Plan to Track MS Drug's Safety
- Aveta Health Illinois Launches Medicare Advantage Special Needs Plans for the Chronically Ill in Cook County
- Medicare Beneficiaries Remain Confused About the New Prescription Drug Benefit and Show Little Interest in Participating, According to New Research From GfK Market Measures
- Research and Markets: Worldwide Prescription Drug Market for Women's Health Forecast to Grow to $11.6 Billion in 2009
 |
 |
User Comments (0)
RSS Feeds